PHUM Presentations and Publications
PHUM Annual Meeting & Review Forum 12th July 2007
The Forum provided a valuable opportunity for the work of our Unit to be critically and objectively evaluated including a review of the lessons learnt over the past three years. Forum discussion also examined and debated future ways of advancing our aim of improving the analysis of patient data, including ensuring workforce experience with prescription data sets, so as to better understand the collective population outcomes which arise from the drug therapies of individuals over the medium to long term.
Publications:
Hall W, Ward R, Liauw W, Lu C, Brien J. Tailoring access to high cost, genetically targeted drugs MJA 2005; 182 (12): 607-608
Mant A, Lowinger J. Everyone's medicines experience can help everyone: The Australian Health Consumer Number One, 2005-2006, Page 23-24
Submissions
Submission to UK Royal Society Project on Pharmacogenetics from the Population Health and Use of Medicines Unit, St Vincent’s Hospital and UNSW, Sydney, Australia [View submission]
Reports:
Hall W, Lucke J. Assessing the impact of medicines on health otucomes: Report to the National Prescribing Service. August 2005 pp1-27
Pearson S, Ringland C, Lowinger J, Stark, H, Tan E, Mant A, Kelman C, Henry D, Day R, Nichols G. Minor Analgesic Use in Veterans: 1998/99 to 2003/04. Report to Department of Veterans’ Affairs, September 2005. pp 1-167
Mant A, Lowinger J, Ringland C, Stark H, Pearson S. Australian Statin Utilisation Trends 1990-2004. Report to Merck Inc. Presented to Merck Sharpe & Dohme Australia. October 2005. pp 1-20
Tan E, Stark H, Lowinger J, Ringland C, Pearson S. Information sources used to guide the pharmacological treatment practices in NSW public hospitals: A qualitative study. Report to Cancer Institute NSW, October 2005. pp 1-49
Pearson S, Ringland C, Kelman C, Lowinger J, Mant A. Using secondary data sources to evaluate the impact of the Joint Heart Failure Program on health outcomes. Report to National Prescribing Service. November 2005. pp 1-100
Presentations:
Mant A. Drug utilisation data - marketing and reimbursement, Pharma Marketing Congress presentation, Sydney, June 23, 2004.
Mant A. How do we use data to better inform QUM across the system? Plenary Panel on Integration and Coordination to ensure effective QUM; National Medicines Symposium, Brisbane, 28-30 July 2004.
Mant A. Population Health & Use of Medicines Unit: An Initiative of the Therapeutics Centre St Vincent’s Hospital and the University of NSW. Poster presentation at National Medicines Symposium, Brisbane, 28-30 July, 2004.
Mant A. Measuring Population Outcomes from Changes in Community Use of Prescribed Medicines: A Strategic Approach, 10th Health Outcomes Conference, Canberra, 15-16 September, 2004 – proceedings in press.
Mant A. Measuring Population Outcomes from Changes in Community Use of Prescribed Medicines: A Strategic Approach, Presentation to the Australian Pharmaceutical Advisory Council (APAC) November 12, 2004.
Mant A. Health outcomes for quality use of medicines - measuring in a new discipline National Prescribing Service Planning Day (NPS) Workshop, Novotel Brighton le Sands Sydney, February 25, 2005.
Pearson S. Measuring population health outcomes from changes in community medicine use: A strategic approach. NSW Therapeutic Assessment Group Meeting, Sydney, February 7, 2005.
Pearson S. Health outcomes from QUM: Taking the next step in measuring the impacts. National Prescribing Service Planning Day, Sydney, February 25, 2005.
Pearson S. Data sources for estimating extent of use on the Pharmaceutical Benefits Scheme. Association of Regulatory and Clinical Scientists (ARCS) Congress, Sydney, May 31, 2005.
Hall W. What is the relationship between SSRI use and suicide? Invited address: World Psychiatric Association Epidemiology meeting, Brisbane, July, 2005.
Hall W. Methods for assessing the effects of medicine use on health outcomes. Invited Presentation. Annual Meeting of the Public Health Use of Medicines Unit, University of New South Wales, Sydney, July, 2005.
Hall W. Methods for assessing the effects of medicine use on health outcomes. Invited Presentation. Evaluation Committee of the National Prescribing Service, Sydney, August, 2005.
Pearson S. Designing and implementing surveys in areas of uncertainty. Association of Regulatory and Clinical Scientists (ARCS) Meeting, Sydney, September 1, 2005.
Mant A. Informing judgements about medicines post-marketing: National Prescribing Service Conference, Sydney, September 7-8, 2005.
Mant A. Data capture for drug utilisation studies. National Prescribing Service Workshop: Utilising national drug utilisation data: Methods for measuring medicines trends and outcomes. Sydney, October 26, 2005.
Lowinger J, Ringland C, Pearson S, Mant A. Australian utilisation of statins and related expenditure: 1990-2004. Poster presentation for 15th Annual St Vincent’s and Mater Health Research Symposium, Sydney, October 14, 2005.
Tan E, Stark H, Lowinger J, Ward R, Pearson S. Understanding the information needs of clinicians treating cancer patients: A qualitative study. Oral presentation for Clinical Oncology Society of Australia 32nd Annual Scientific Meeting, Brisbane, 16-18 November, 2005,
Mant A, Ward R. The evidence base for new pharmaceuticals in cancer treatment: Surrogate and real health outcomes. Plenary Symposium, Clinical Oncological Society of Australia Annual Meeting, Brisbane, November, 2005
"Better Use of Better Data"